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Abstract
Background: Knowledge of the subcellular localization of a protein can provide useful insights
about its function. While the subcellular localization of many alphaherpesvirus UL51 proteins has
been well characterized, little is known about where duck enteritis virus (DEV) UL51 protein
(pUL51) is targeted to. Thus, in this study, we investigated the subcellular localization and
distribution of DEV pUL51 by computer aided analysis, as well as indirect immunofluorescence (IIF)
and transmission immunoelectron microscopy (TIEM) approaches in DEV-infected cells.
Results: The DEV UL51 gene product was identified as an approximate 34 kDa protein in DEV-
infected cells analyzed by western blotting. Computer aided analysis suggested that DEV pUL51 is
not targeted to the mitochondrial, extra-cellular or nucleus, but be targeted to the cytoplasmic in
host cells, more specifically, palmitoylation of the pUL51 through the N-terminal cysteine at
position 9 makes membrane association and Golgi localization possible. Using IIF analysis, we found
that DEV pUL51 was first detected in a juxtanuclear region of DEV-infected cells at 9 h
postinfection (p.i.), and then was detected widely distributed in the cytoplasm and especially was
stronger in the juxtanuclear region from 12 to 60 h p.i. TIEM analysis revealed that DEV pUL51 was
mainly associated with cytoplasmic virions and also with some membranous structure near the
pUL51-specific immuno-labeling intracellular virion in the cytoplasmic vesicles; moreover, the
pUL51 efficiently accumulated in the Golgi apparatus at first, and then was sent to the plasma
membrane from the Golgi by some unknown mechanism.
Conclusion: In this work, we described the basic characteristics of pUL51 subcellular localization
and distribution for the first time. From these results, we concluded that palmitoylation at the N-
terminal cysteine, which is conserved in all alphaherpesvirus UL51 homologs, is required for its
membrane association and Golgi localization, and the pUL51 mainly localized to the juxtanuclear
region of DEV-infected cells, as well seemed to be incorporated into mature virions as a
component of the tegument. The research will provide useful clues for DEV pUL51 functional
analysis, and will be usefull for further understanding the localization properties of alphaherpesvirus
UL51 homologs.
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Duck enteritis virus (DEV) is a member of the subfamily
Alphaherpesvirinae, and an important pathogen of water-
fowl (ducks, geese, and swans), causing an acute conta-
gious viral disease that result in substantial economic
losses [1-3]. The genome of DEV is comprised of an
approximate 180 kbp of linear and double-stranded DNA
molecule, and its genomic structure is similar to that of
other alphaherpesviruses [4,5]. In 2006, the DEV UL51
gene was isolated and identified from DEV CHv strain in
our laboratory [6,7]. It was reported that UL51 gene of the
alphaherpesviruses, which encodes a phosphorylated and
palmitoylated tegument protein [8,9], and was high con-
served in the alphaherpesvirus family [10]. Recent
research has shown that the product of the herpes simplex
virus (HSV-1) UL51 gene is a membrane associated pro-
tein, eventually incorporated into virions and forming the
outer layer of tegument [9,11]; moreover, the HSV-1 UL51
protein (pUL51) appears to play multiple roles in viral
replication, including egress of virus particles from the
perinuclear space and secondary envelopment in the cyto-
plasm [12].
The infective properties of a virus are determined by the
viral proteins that make up its capsid, envelope (tegu-
ment), and spikes. Although viruses are acellular organ-
isms, viral proteins are required to reside in various
cellular compartments of the host cell to fulfill their func-
tions [13]. Therefore, knowledge of the subcellular locali-
zation of viral proteins in a host cell or virus-infected cell
is very useful for in-depth studying of their functions and
mechanisms as well as designing antiviral drugs. While
the intracellular localization of many alphaherpesvirus
UL51 proteins, such as HSV-1 [11], bovine herpesvirus 1
(BHV-1) [14], and pseudorabies virus (PrV) [15], has been
well characterized, little is known about where DEV
pUL51 is targeted to. In the present study, we character-
ized the DEV pUL51 subcellular localization by computer
aided analysis, as well as indirect immunofluorescence
(IIF) and transmission immunoelectron microscopy
(TIEM) approaches in DEV-infected cells. There would be
a strong degree of complementarity between the use of
computational tools and experimental methods that can
score the likelihood that DEV pUL51 belongs to a given
compartment. The research will provide useful clues for
DEV pUL51 functional analysis, and will be usefull for




The DEV UL51 gene (GenBank No. DQ072725), with a
size of 759 bp, encoded a 252 amino acid protein, was
identified in our laboratory [6]. Based on predicted amine
acid sequence of DEV pUL51, various bioinformatics-
aided tools: TargetP 1.1, SignalP 3.0 and TMHMM 2.0
server (from the search engine http://www.cbs.dtu.dk/
services/) [16], PredictNLS server (from the search engine
http://www.rostlab.org/services/predictNLS/) [17], CSS-
Palm 2.0 online server (from the search engine http://
csspalm.biocuckoo.org/online.php) [18], and Golgi pre-
dictor (from the search engine http://ccb.imb.uq.edu.au/
golgi/golgi_predictor.shtml) [19], were used to analyze
the possible localization of the pUL51.
Virus strain and cell
DEV CHv strain is a high-virulence field strain isolated
from china, obtained from Key Laboratory of Animal Dis-
ease and Human Health of Sichuan Province [20,21].
Duck embryo fibroblasts (DEF) were cultured in MEM
medium (Gibco-BRL) supplemented with 10% fetal
bovine serum (FBS) (Gibco-BRL) at 37°C. For virus infec-
tion, MEM medium supplemented with 2–3% FBS was
used.
Antibody
A rabbit polyclonal UL51 antiserum (obtained from our
Laboratory), raised against a recombinant 6-His-UL51
fusion protein expressed in E. coli, was purified using
caprylic acid and ammonium sulfate precipitation and
High-Q anion-exchange chromatography [22,23]. The
purified UL51 antiserum was subsequently used as pri-
mary antibody. Besides, a pre-immune rabbit serum was
also obtained from our Laboratory and purified as
described above. The purified pre-immune serum was
used as a negative control.
Western blotting
DEF grown in the 6-well plates, were either mock-infected
or infected with DEV CHv strain at a multiplicity of 5 PFU
per cell, and harvested at 24 h p.i. Cells were lysed in SDS
sample buffer, electrophoretically separated on SDS-poly-
acrylamide gels (SDS-PAGE) and electrically transferred to
polyvinylidene difluoride (PVDF) membranes (Amer-
sham Japan). A nonspecific protein binding was blocked
by treating membranes at 4°C overnight with TBST (25
mmol Tris-HCl, 150 mmol NaCl, pH 7.4, and 0.05%
Tween-20) containing 5% bovine serum albumin (BSA).
Then, the membranes were incubated at 37°C for 1 h with
a 1:1000 dilution of the purified UL51 antiserum or pre-
immune serum in TBST containing 0.1% BSA. After wash-
ing 3 times with TBST, the membranes were incubated at
37°C for 1 h with a 1:10000 dilution of goat anti-rabbit
peroxidase-labeled second antibody (Sino-American Bio-
technology Co., Shanghai, China). Washed 3 times with
TBST again, the membranes were subsequently treated
with an enhanced chemiluminescence (ECL) western
blotting detection system (Amersham) and exposed to
Hyperfilm-ECL (Amersham).Page 2 of 8
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DEF, grown on coverslips in the 6-well plates, were either
mock-infected or infected as described above. At different
times (3, 6, 9, 12, 24, 36, 48 and 60 h p.i.), the cells were
fixed with 4% paraformaldehyde for 20 min at 4°C and
permeabilized with 0.1% Triton X-100 for 20 min at room
temperature. The cells were then washed once with PBS
and blocked for 1 h in PBS containing 10% BSA at 37°C.
They were then incubated with a 1:100 dilution of the
purified UL51 antiserum or pre-immune serum at 4°C
overnight, washed 3 times for 10 min in PBS, and then
treated with FITC conjugated goat anti-rabbit IgG (Sino-
American Biotechnology Co.) for 45 minutes at 37°C. As
described by Miller [24], the cell nuclei were visualized by
4',6-diamidino-2-phenylindole (DAPI) counter-staining
(5 μg/ml, Beyotime Institute of Biotechnology, Shanghai,
China). Fluorescent images were examined under the Bio-
Rad MRC 1024 imaging system.
TIEM
DEF were grown in the 6-well plates and were either
mock-infected or infected as described above. At different
times (3, 6, 9, 12, 24, 36, 48 and 60 h p.i.), the cells were
fixed with modified PLP fixative (10 mM NaIO4, 75 mM
lysine, 37.5 mM phosphate buffer (PB) (pH 7.4), 4%
paraformaldehyde, 0.1% glutaraldehyde) for 4 h and then
washed with 0.1 M PB [25]. The cells were then harvested
from the 6-well plates by scraping, resuspended in PB, and
pelleted by low-speed centrifugation. The cell pellet was
washed with PB, dehydrated through a graded series of
ethanol, and embedded in LR White resin (London Resin
Company) according to the manufacturer's instructions.
Ultrathin sections were collected onto Formvar-coated
nickel grids. The sections were incubated with 20% nor-
mal goat serum in PBS containing 1% BSA for 1 h at room
temperature, washed five times in PBS, and incubated
with the purified UL51 antiserum or pre-immune serum
adequately diluted in PBS-1% BSA for 2 h. After five
washes in PBS, the sections were incubated for 1 h with
the secondary antibody goat anti-rabbit immunoglobulin
conjugated with 10-nm-diameter gold particles (British
BioCell International) and then washed five times in PBS
and twice in double-distilled water. The sections were
double stained with 4% uranyl acetate for 30 min fol-
lowed by Reynold's lead citrate solution for 5 min [11].
Carbon-coated sections were examined with a Hitachi H-
600 transmission electron microscope at 75 kV.
Results
Subcellular localization prediction of DEV pUL51
The DEV pUL51 contains no potential mitochondrial tar-
geting peptide, signal peptides, transmembrane helices
and nuclear localization signal (NLS). However, it pos-
sesses one potential palmitoylation site at the position 9
amine acid (cysteine) near the N-terminal of the pUL51
with a high score (4.217). Moreover, the pUL51 is pre-
dicted as a Golgi type II membrane protein (Golgi local-
ised transmembrane protein) with index values (20.662)
greater than the threshold (20.005).
Reactivity and specificity of the UL51 antiserum
The purified UL51 antiserum and pre-immune serum was
examined by SDS-PAGE (Fig 1A, lanes 1 and 2). To exam-
ine the reactivity and specificity of the UL51 antiserum,
SDS-PAGE and western blotting was performed (Fig 1B,
lanes 1 to 6). The results of western blotting showed that
the UL51 antiserum reacted strongly with an approximate
34 kDa protein in lysates of DEV-infected cells (Fig 1B,
lane 5). This band was not detected in mock-infected cells
(Fig 1B, lane 4), and the pre-immune serum did not rec-
ognize any proteins in lysates of DEV-infected cells (Fig
1B, lane 6). These results indicated that the UL51 antise-
rum specifically detected the primary translation product
of the UL51 gene; therefore, we used this UL51 antiserum
for further experiments to study the locations of the DEV
pUL51.
Intracellular localization and distribution of DEV pUL51 in 
DEV-infected cells
A detailed analysis of the intracellular localization of DEV
pUL51 was investigated using the purified UL51 antise-
rum or pre-immune serum by IIF staining of mock- and
(A) SDS-PAGE analysis of the purified UL51 antiserum and pre-immune serumFigure 1
(A) SDS-PAGE analysis of the purified UL51 antise-
rum and pre-immune serum. The purified IgG proteins 
of UL51 antiserum and pre-immune serum were respectively 
examined by SDS-PAGE (lanes 1 and 2). Molecular mass 
markers (in kDa) are shown to the left (lane M). H and L 
respectively indicate the position of heavy and light chains of 
the IgG proteins. (B) Reactivity and specificity of the 
purified UL51 antiserum analyzed by western blot-
ting. DEF were mock-infected (lanes 1 and 4) or infected 
with DEV CHv strain (lanes 2, 3, 5 and 6) and harvested at 24 
h p.i. The pUL51 was separated by SDS-PAGE (lanes 1 to 3) 
and analyzed by western blotting using the UL51 antiserum 
(lanes 4 and 5) or the pre-immune serum (lane 6). Molecular 
mass markers (in kDa) are shown to the left (lane M). The 
arrowhead indicates the position of the pUL51 (about 34 
kDa).Page 3 of 8
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cific fluorescence was first detected in the cytoplasm of
DEV-infected cells at 9 h p.i. (Fig 2C), and then a strong
fluorescence was observed mainly in the juxtanuclear
region at 12 h p.i. (Fig 2D). After that, the pUL51-specific
fluorescence in the juxtanuclear region was dense and
localized on wide areas of the cytoplasm. At 36 h p.i. (Fig
2E), the pUL51-specific fluorescence was found widely
distributed in the cytoplasm and especially was stronger
in the juxtanuclear region; meanwhile, the nucleus of
some DEV-infected cells also contained little fluorescence
granular. Following by a series of morphological changes,
the cytoplasm disintegration and nuclear fragmentation
in DEV-infected cells, the intensity of the reaction
increased at 48 and 60 h p.i. (Fig 2F), while the pUL51-
specific fluorescence was mainly detected in the cyto-
plasm of infected cells and that one localized in the
nuclear was faint. No pUL51-specific fluorescence could
be detected in mock-infected cells reacted with the UL51
antiserum (Fig 2A) and in DEV-infected cells reacted with
the pre-immune serum (Fig 2B).
Subcellular localization and distribution of DEV pUL51 in 
DEV-infected cells
To identify the precise localization of DEV pUL51 in DEV-
infected cells, TIEM was carried out. Immunoelectron
microscopy showed that at 6 h p.i., only a little pUL51-
specific immuno-labeling was first observed in the cyto-
plasm of DEV-infected cells (data not shown). At 12 h p.i.,
intense pUL51-specific immuno-labeling was detected in
the juxtanuclear region (Fig. 3B), probably associated
with Golgi apparatus. After that, ultrastructural changes of
DEV-infected cells were especially remarkable, an increas-
ing number of virus particles were accumulated in the
cytoplasm with expansion of endoplasmic reticulum and
formation of specialized vesicles. Starting from 24 h p.i.,
some immuno-labeling was found being associated with
cytoplasmic virions and also with some membranous
structure that was observed near the pUL51-specific
immuno-labeling cytoplasmic virions in the cytoplasmic
vesicles (Fig. 3C), and thereafter increasingly until 48 p.i.
(Fig. 3D). At later times (60 h p.i.), the positive labeling
was mainly localized in the cytoplasm and especially was
scattered near the plasma membrane of DEV-infected cell
(data not shown). No pUL51-specific immuno-labeling
was seen in the DEV-infected cells reacted with the pre-
immune serum (Fig. 3A) and in the mock-infected cells
reacted with the UL51 antiserum (data not shown).
Discussion
Proteins must be localized in the same sub-cellular com-
partment to co-operate towards a common biological
function. The native subcellular localization of a protein
is important for the understanding of its function [17].
However, due to the difficulties in the experimental deter-
mination of protein's cellular localization, the methods of
theoretical prediction on the known sequence are becom-
ing more important [26]. Computational tools provide
fast and accurate localization predictions for any organ-
ism [17]. Generally, proteins are sorted into one of four
localization classes: extra-cellular, cytoplasmic, nuclear
and mitochondrial [27]. Our results of computer aided
analysis revealed that the DEV pUL51 is not targeted to
the mitochondrial, extra-cellular or nucleus, suggesting
that it is targeted to the cytoplasmic in host cells, similar
to the homologous proteins of HSV-1, BHV-1, and PrV
[11,14,15].
Protein palmitoylation is one of the most ubiquitous
post-translational modifications, reversibly attaching a
16-carbon saturated fatty acid as lipid palmitate to
cysteine residues in protein substrates through thioester
linkage. Also, palmitoylation is thought to be important
in regulating intracellular trafficking, sorting, subcellular
localization, protein-protein interactions, and functional
activities of the proteins [28,29]. It has been reported that
a number of viruses encode palmitoylated proteins, which
play important roles in the process of virus replication
[11,30-36]. In additional, previous reports have shown
that palmitoylation of the N-terminal cysteine at position
9 (Cys-9) of the HSV-1 pUL51 is necessary for targeting to
the Golgi apparatus [11]. From our results, one palmi-
toylation site is predicted at 9th cysteine of the DEV
pUL51, suggesting that the pUL51 is also palmitoylation,
and shares higher levels of homology with that of HSV-1.
We thus inferred that palmitoylation at the N-terminal
cysteine, which is conserved in all alphaherpesvirus UL51
homologs [15], is required for its membrane association
and Golgi localization, although we cannot rule out the
possibility that the pUL51 has another signal for its sub-
cellular localization.
As we known, the Golgi Apparatus is an organelle central
to the biosynthetic pathway of eukaryotic cells as it plays
a principal role in the post-translational modification of
newly synthesized proteins and in the sorting, packaging
and distribution of these proteins to various destinations.
To date, all the endogenous single membrane spanning
proteins resident within the Golgi apparatus are Type II
(cytoplasmic N-terminus/lumenal C-terminus) [19]. Our
results of computer aided analysis indicated that the DEV
pUL51 is also a Type II membrane protein, which con-
tains a cytoplasmic N-terminus. Taking the above results,
it is possible that the DEV pUL51 residents in the Golgi
apparatus.
Furthermore, experimentally unravelling the native com-
partment of a protein also constitutes one step on the long
way to determining its function [17]. Experimental deter-
mination of a protein subcellular localization is mainlyPage 4 of 8
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Intracellular location and distribution of DEV pUL51 analyzed by IIFFigur  2
Intracellular location and distribution of DEV pUL51 analyzed by IIF. Mock-infected (A) and DEV-infected (B to F) 
DEF were fixed as described in Materials and Methods. The samples were stained with the UL51 antiserum (A, C to F) or pre-
immune serum (B), and reacted with anti-rabbit IgG-conjugated FITC, and then counter-stained with DAPI (blue is representa-
tive the cell nuclei). The merged fluorescence microscopy images of DEF are shown in panels A to F with high magnification 
(600×).
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Subcellular location and distribution of DEV pUL51 analyzed by TIEMFigure 3
Subcellular location and distribution of DEV pUL51 analyzed by TIEM. Thin sections were prepared as described in 
Materials and Methods and incubated with the UL51 antiserum (B to D) or pre-immune serum (A) after treatment with 20% 
normal goat serum to block nonspecific antibody reactions. Samples were then incubated with anti-rabbit IgG-conjugated 10-
nm-diameter gold particles. After extensive rinsing, sections were stained with uranyl acetate and lead citrate and examined 
with a Hitachi H600 transmission electron microscope at 75 kV. No specific immunolabeling was seen in the cells reacted with 
pre-immune serum (A). Immunolabelling for pUL51 (arrows) was found in the juxtanuclear region (B). Some immunolahelling 
for pUL51 (arrows) was found being associated with cytoplasmic virions and also with some membranous structure in the 
cytoplasmic vesicles (C and D). Abbreviations: Cyt, cytoplasm; Nu, nucleus. Bars represent 100 nm.
Virology Journal 2009, 6:92 http://www.virologyj.com/content/6/1/92accomplished by three approaches: cell fractionation, flu-
orescence microscopy and electron microscopy. Due to
the cell fractionation approach is very sensitive to contam-
inations, we chose the fluorescence microscopy and elec-
tron microscopy approach to investigate the
characteristics of pUL51 subcellular localization in this
study.
Firstly, the results of IIF analyses revealed DEV pUL51 was
found predominantly in the cytoplasm and especially in
the juxtanuclear region, where they were detected as
speckled or punctuate patterns in DEV-infected cells.
These patterns are very similar to HSV-1 [11], BHV-1 [14]
and PrV [15] pUL51 in viral infected cells. Moreover,
Nozawa et al. reported that HSV-1 pUL51 localized to the
juxtanuclear region, but only partially colocalized with
the Golgi maker proteins such as the Golgi 58K protein
and Golgi Matrix Protein (GM130) in HSV-1 infected cells
[11]. Thus, combined with the mentioned above, we
inferred that DEV pUL51 might remain mainly concen-
trated in the Golgi apparatus and ensures its incorpora-
tion into assembling virions.
Secondly, our TIEM analysis showed that an association
of DEV pUL51-specific labeling with cytoplasmic virions
and also with some membranous structure observed near
the intracellular virion. Previous studies have reported
that the HSV-1 pUL51 is eventually incorporated into vir-
ions and localized mainly to the inner side of cytoplasmic
vesicles and/or the viral envelope in viral infected cells
using protease digestion analysis [11]. These abservations
suggested that the DEV pUL51 might be associated with
viral envelopment in DEV-infected cells, and seemed to be
incorporated into mature virions as a component of the
tegurneut, similar to the HSV-1 pUL51.
Besides, it is reported that both proteins, HSV-1 UL11 and
UL51, seem to contain specific Golgi-targeting signals,
suggesting that both proteins might serve similar func-
tions [15]. Recently, Loomis et al. reported that the tegu-
ment protein UL11 localizes to both the Golgi apparatus
and the plasma membrane in HSV-1-infected cells [37].
Thus, like the HSV-1 UL11 protein, the DEV pUL51 also
might efficiently accumulate in the Golgi apparatus at
first, and then were sent to the plasma membrane from
the Golgi by some unknown mechanism.
Conclusion
In this study, we described the basic characteristics of
pUL51 subcellular localization and distribution for the
first time. From these results, we concluded that palmi-
toylation at the N-terminal cysteine, which is conserved in
all alphaherpesvirus UL51 homologs, is required for its
membrane association and Golgi localization, and the
pUL51 mainly localized to the juxtanuclear region of
DEV-infected cells, as well seemed to be incorporated into
mature virions as a component of the tegument, consist-
ent with its HSV-1 homolog UL51. The research will pro-
vide useful clues for DEV pUL51 functional analysis, and
will be usefull for further understanding the localization
properties of alphaherpesvirus UL51 homologs. Further
studies will be aimed at constructing of the UL51 gene
DEV mutant to study the function of the DEV pUL51.
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